Comparison of hazard models with and without consideration of competing risks to assess the effect of neoadjuvant chemotherapy on locoregional recurrence among breast cancer patients
Conclusions: Competing risks, if any, need to be incorporated in the survival analysis. NACT was found to be associated with higher risk for LRR, which may be because of administering it mainly to patients with bad prognosis.
Conclusions: Competing risks, if any, need to be incorporated in the survival analysis. NACT was found to be associated with higher risk for LRR, which may be because of administering it mainly to patients with bad prognosis.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Mona Pathak Surya Narayana V S. Deo Sada Nand Dwivedi Sreenivas Vishnubhatla Bhaskar Thakur Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | India Health | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Skin | Statistics | Study